Difamilast Ointment in Japanese Adult and Pediatric Patients with Atopic Dermatitis: A Phase III, Long-Term, Open-Label Study

被引：0
|
作者：
Hidehisa Saeki
Tomomi Imamura
Daisuke Yokota
Hidetsugu Tsubouchi
机构：
[1] Nippon Medical School,Department of Dermatology
[2] Otsuka Pharmaceutical Co.,Headquarters of Clinical Development
[3] Ltd.,Headquarters of Clinical Development
[4] Otsuka Pharmaceutical Co.,Medical Affairs
[5] Ltd.,undefined
[6] Otsuka Pharmaceutical Co.,undefined
[7] Ltd.,undefined
来源：
Dermatology and Therapy | 2022年 / 12卷
关键词：
Application; Atopic dermatitis; Difamilast; Japanese adult and pediatric patients; Ointment; Open-label study; Phosphodiesterase 4; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1589 / 1601
页数：12
相关论文
共 50 条
  • [1] Difamilast Ointment in Japanese Adult and Pediatric Patients with Atopic Dermatitis: A Phase III, Long-Term, Open-Label Study
    Saeki, Hidehisa
    Imamura, Tomomi
    Yokota, Daisuke
    Tsubouchi, Hidetsugu
    DERMATOLOGY AND THERAPY, 2022, 12 (07) : 1589 - 1601
  • [2] An Interim Report of a Phase 3, Long-Term, Open-Label Study to Evaluate Efficacy and Safety of Difamilast Ointment in Japanese Infants with Atopic Dermatitis
    Saeki, Hidehisa
    Ohya, Yukihiro
    Baba, Naoko
    Imamura, Tomomi
    Yokota, Daisuke
    Tsubouchi, Hidetsugu
    DERMATOLOGY AND THERAPY, 2024, 14 (09) : 2443 - 2455
  • [3] Tacrolimus ointment is safe and effective in the treatment of atopic dermatitis - Results of two large long-term open-label studies in pediatric and adult patients
    Lawrence, I
    ALLERGY FRONTIERS AND FUTURES, 2003, : 269 - 271
  • [4] Safety, efficacy, and pharmacokinetics of delgocitinib ointment in infants with atopic dermatitis: A phase 3, open-label, and long-term study
    Nakagawa, Hidemi
    Igarashi, Atsuyuki
    Saeki, Hidehisa
    Kabashima, Kenji
    Tamaki, Tomomi
    Kaino, Hironobu
    Miwa, Yasushi
    ALLERGOLOGY INTERNATIONAL, 2024, 73 (01) : 137 - 142
  • [5] Delgocitinib ointment in pediatric patients with atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and a subsequent open-label, long-term study
    Nakagawa, Hidemi
    Nemoto, Osamu
    Igarashi, Atsuyuki
    Saeki, Hidehisa
    Kabashima, Kenji
    Oda, Manabu
    Nagata, Takeshi
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (04) : 854 - 862
  • [6] Delgocitinib ointment in pediatric patients with atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and an open-label, long-term extension study
    Nakagawa, Hidemi
    Nemoto, Osamu
    Igarashi, Atsuyuki
    Saeki, Hidehisa
    Kabashima, Kenji
    Oda, Manabu
    Nagata, Takeshi
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB52 - AB52
  • [7] Topically applied tacrolimus ointment in pediatric atopic dermatitis patients: Results of a large open-label study
    Schneider, L
    Roberts, R
    Berger, W
    Prenner, BM
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (01) : S160 - S160
  • [8] An open-label, long-term, phase III extension trial of duloxetine in Japanese patients with fibromyalgia
    Murakami, Masato
    Osada, Kenichi
    Ichibayashi, Hisao
    Mizuno, Hiromichi
    Ochiai, Toshimitsu
    Ishida, Mitsuhiro
    Alev, Levent
    Nishioka, Kusuki
    MODERN RHEUMATOLOGY, 2017, 27 (04) : 688 - 695
  • [9] A single-center open-label long-term comparison of tacrolimus ointment and topical corticosteroids for treatment of atopic dermatitis
    Neumann, Ella
    Amtage, Dorothee
    Bruckner-Tuderman, Leena
    Mockenhaupt, Maja
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2008, 6 (07): : 548 - 554
  • [10] Difamilast a topical PDE4 inhibitor: Phase 3 trials in Japanese adult and pediatric patients with atopic dermatitis
    Tanaka, Akio
    Hide, Michihiro
    Tsuchiya, Takahiro
    Ito, Kensuke
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB67 - AB67
12345